Literature DB >> 18823863

Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome.

Carmel Kalla1, David Raveh, Nurit Algur, Bernard Rudensky, Amos M Yinnon, Jonathan Balkin.   

Abstract

BACKGROUND: Since the introduction of troponin for the diagnosis of myocardial infarction, several studies have shown additional conditions in which troponin is elevated, including sepsis. The objective of this study was to determine the incidence of an elevated troponin in patients with bacteremia and its significance.
METHODS: This was a prospective, noninterventional study. Patients with a positive blood culture were included. Cardiac troponin I (cTnI) was determined within 4 days of blood culture. A repeat electrocardiogram was obtained in a sample of patients with elevated cTnI and in patients with a negative troponin test. Demographic, clinical, and microbiological data were obtained for all patients.
RESULTS: A total of 159 bacteremic patients were included. Positive cTnI was detected in 69 patients (43%). Elevated cTnI was associated with a number of underlying diseases, hospitalization ward, severity of the systemic inflammatory condition, and kidney function (P<.05-.001). A repeat electrocardiogram was performed in 39 patients with a positive cTnI and in 28 patients with a negative cTnI. Two of 39 patients (5%) in the positive cTnI group had ischemic changes and 2 patients (5%) had nonspecific changes, whereas only 1 patient (4%) with a negative cTnI had nonspecific changes. Bivariate analysis revealed a statistically significant association for positive cTnI and mortality; however, on multivariate analysis this was no longer significant.
CONCLUSION: Forty-three percent of bacteremic patients had an elevated cTnI. Risk factors for elevated cTnI were severity of the underlying infection, renal function, and underlying cardiac disease. Increased cTnI was found to be a dependent risk factor and a surrogate marker for death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823863     DOI: 10.1016/j.amjmed.2008.05.037

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  [Sepsis and heart].

Authors:  H Ebelt; K Werdan
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 2.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

Review 3.  Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review.

Authors:  Vasileios Zochios; Kamen Valchanov
Journal:  J Intensive Care Soc       Date:  2014-12-09

4.  Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome.

Authors:  Hafidh A Al-Hadi; Keith A Fox
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

Review 5.  [Septic circulatory shock and septic cardiomyopathy].

Authors:  K Werdan; S Hettwer; S Bubel; A Oelke; R S Hoke; R Wimmer; H Ebelt; U Müller-Werdan
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

Review 6.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction.

Authors:  Leroy C Joseph; Michael V Reyes; Kundanika R Lakkadi; Blake H Gowen; Gyorgy Hasko; Konstantinos Drosatos; John P Morrow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

8.  Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications.

Authors:  Joachim Wilhelm; Stefan Hettwer; Markus Schuermann; Silke Bagger; Franziska Gerhardt; Sandra Mundt; Susanne Muschik; Julia Zimmermann; Mroawan Amoury; Henning Ebelt; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2014-02-18       Impact factor: 5.460

9.  Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy.

Authors:  Dimitra Kokkinaki; Matthew Hoffman; Charikleia Kalliora; Ioannis D Kyriazis; Jennifer Maning; Anna Maria Lucchese; Santhanam Shanmughapriya; Dhanendra Tomar; Joon Young Park; Hong Wang; Xiao-Feng Yang; Muniswamy Madesh; Anastasios Lymperopoulos; Walter J Koch; Melpo Christofidou-Solomidou; Konstantinos Drosatos
Journal:  J Mol Cell Cardiol       Date:  2019-01-03       Impact factor: 5.000

10.  Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial function.

Authors:  Leroy C Joseph; Dimitra Kokkinaki; Mesele-Christina Valenti; Grace J Kim; Emanuele Barca; Dhanendra Tomar; Nicholas E Hoffman; Prakash Subramanyam; Henry M Colecraft; Michio Hirano; Adam J Ratner; Muniswamy Madesh; Konstantinos Drosatos; John P Morrow
Journal:  JCI Insight       Date:  2017-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.